| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Development Officer | Director
2 companies
Forbes William P serves as an EVP, Chief Development Officer at HRTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 5 buys and 0 sells. Those positions are worth an estimated $99K at current prices.
Historically, Forbes William P's trades have earned a below-average insider score of 49/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -28.5%.
The biggest single holding is XAIR (~$99K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 14,855 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Chief Development Officer | Buy | 25,000 | $1.09 | $27,250.00 | +46.3% | +164.2% | +9.2% | |
| Nov 16, 2023 | HRTX Heron Therapeutics, Inc. /de/ | EVP, Chief Development Officer | Buy | 50,000 | $0.94 | $46,995.00 | +1,250% | +196.7% | +29.8% | |
| Mar 31, 2023 | XAIR Beyond Air, Inc. | Director | Buy | 5,000 | $6.67 | $33,350.00 | +50.7% | -32.1% | -76.6% | |
| Mar 17, 2023 | XAIR Beyond Air, Inc. | Director | Buy | 5,000 | $6.46 | $32,300.00 | +103.0% | -7.4% | -76.2% | |
| Jun 3, 2019 | XAIR Beyond Air, Inc. | Director | Buy | 4,855 | $5.15 | $25,003.25 | New | - | - |